Skip to content
CES 2027
CES
2027

WE, COSMAS BIOSCIENCE

CEO

Hojeong Yu Ph.D.

COSMAS BIOSCIENCE is committed to solving the most pressing
issues in today's centralized healthcare system—high costs,
long wait times, and limited access.

To overcome these challenges, we are developing an AI-powered,
on-device digital healthcare solution
that delivers faster,
more personalized care directly to individuals.

Our ultra-sensitive, point-of-care multiplex diagnostic platform
enables precision medicine and supports daily health management
tailored to each person.

By integrating advanced biotechnology, nanotechnology,
and information & communication technology
, we have created
world-class, groundbreaking innovations.

With this foundation, we are pioneering
the AI-driven digital healthcare and personalized wellness market,
positioning ourselves as a leading force in the industry.

Our mission is clear: to deliver smarter, more precise care
that improves lives and makes the world a healthier place.

Education

  • University of Illinois at Urbana-ChampaignElectrical and Computer Engineering, PhD (2017)
  • Yonsei UniversityElectrical and Electronic Engineering, MS (2011)
  • Yonsei UniversityElectrical and Electronic Engineering & Physics (Double Major) (2009)

Career

  • COSMAS Bioscience, CEO (2024~Present)
  • Gwangju Institute of Science and Technology (GIST), Research Professor (2023~2024)
  • Harvard Medical School, Postdoctoral Research Fellow (2017~2022)

Publications

  • Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device, Nat. Biomed. Eng. 4, 1159-1167 (2020)
  • A rapid assay provides on-site quantification of tetrahydrocannabinol in oral fluid, Sci. Transl. Med. 13, abe2352 (2021)